Two Hot Stocks on the Run: Nektar Therapeutics (NASDAQ:NKTR), Hi-Crush Partners LP (NYSE:HCLP)

Nektar Therapeutics (NASDAQ:NKTR)

The shares of Nektar Therapeutics (NASDAQ:NKTR) started off the last trading session with the price of $107.17 while closing the day with the price of $108.34. The shares of Nektar Therapeutics (NASDAQ:NKTR) Fell -0.09% with the Gain of 1.17 points.

The shares of Nektar Therapeutics (NASDAQ:NKTR) traded with the day volume of 1.85 Million shares whereas its average trading volume is 2.52 Million.

While analyzing the past performance of the stock we can see that the shares of Nektar Therapeutics (NASDAQ:NKTR) Gain 5.32% in the last week while rising 41.49% in the last month. Past quarter performance shows the green light with 118.03%. The semi-annual and annual performance shows 382.15% and 607.18% respectively.

Some critical values of the shares of Nektar Therapeutics (NASDAQ:NKTR) to be discussed here are: the beta which shows the value at 1.9 while Average True Range of Nektar Therapeutics (NASDAQ:NKTR) demonstrate the value at 6.4. The weekly and monthly volatility of the shares of Nektar Therapeutics (NASDAQ:NKTR) are indicated at 5.17% and 6.84%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 72.72.

While studying the financial position of the shares of Nektar Therapeutics (NASDAQ:NKTR), we can see that the Market capitalization of the company is at 17.08 Billion. The shares outstanding for the company is 157.61 Million and the shares float stands at 155.9 Million. The income of the company stand at -96700000 while the sales stand at 307.7 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.64, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 55.49, the Return on Asset ROA stood at -0.185 and the Return on Equity ROE depicted at -1.757 while Return on Investment ROI is at -0.181.


Hi-Crush Partners LP (NYSE:HCLP)

Hi-Crush Partners LP (NYSE:HCLP) started its previous trading session at $13.2 and closed at $12.95 showing a Rise of 1.57 Percent.

The Company traded with an average Volume of 1.87 Million whereas, its Day Volume stood at 1.85 Million.

Looking at the performance of the stock, Hi-Crush Partners LP (NYSE:HCLP) Gain 4.86% in the last week in its shares price and 10.68% in the last month. Quarterly performance shows a green of 29.5 Percent while Semi-Annual and Annual performances shows a 59.88 and -16.18 percent respectively.

Beta for Hi-Crush Partners LP (NYSE:HCLP) stands at 1.14 while the ATR (average true range) is at 0.66. The Stock’s Weekly and Monthly Volatility is 4.49% and 5.54% respectively showing a RSI value of 58.39.

While studying the financial position of the shares of Hi-Crush Partners LP (NYSE:HCLP), we can see that the Market capitalization of the company is at 1.16 Billion. The shares outstanding for the company is 89.62 Million and the shares float stands at 77.85 Million.

The Company generated an income of 84 Million and the sales of 602.6 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $0.9 a share. P/E (price to earnings) and P/S (price to sales) values are 14.47 and 1.93 respectively.

The Return on Assets stands at 0.078, ROE shows a value of 0.109 and ROI for Hi-Crush Partners LP (NYSE:HCLP) is 0.094 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment